PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast

Kent E. Vrana, PhD, FAAAS, FASPET - Mastering Cannabinoid Science: Key Insights for Informed Clinical Decision-Making

Kent E. Vrana, PhD, FAAAS, FASPET - Mastering Cannabinoid Science: Key Insights for Informed Clinical Decision-Making

Nitin Jain, MD - Committing to Advances for CLL Care: Conversations on Modern Standards of Care and Next-Gen Innovation

M. Camille Hoffman, MD, MSc - From Screening Through Treatment: Proactive Engagement of Patients in Team-Based Care for PPD

Komal Jhaveri, MD, FACP - Visual Exploration of the Evolving Role of Novel Oral SERDs, Other ER-Targeting Therapies, and Rational Combinations in ER+, HER2- MBC

Julie R. Brahmer, MD, MSc, FASCO - Maximizing the Potential and Expanding the Impact of Immunotherapy in Advanced NSCLC

Komal Jhaveri, MD, FACP - Changing the Scenery in ER+, HER2- MBC With New Oral SERDs and Combinations: Foundations, Evidence, and Practicalities

Jennifer Hsiao, MD - Don’t Miss Hidradenitis Suppurativa: Providing Timely Diagnosis and Management Using Novel Agents

Paul Kwo, MD, AGAF, FACG, FAASLD - The Path to Viral Hepatitis Elimination: Enhancing Screening, Vaccination, Treatment, and Care

Kathleen M. Buchheit, MD, Joseph K. Han, MD, FARS, FAAAAI - Navigating Biologic Therapy in CRSwNP: From Patient Selection to Response Assessment

Krish Patel, MD - Mapping Therapeutic Directions in DLBCL: Team Strategies for Prognostic Assessment and Implications for Targeted Therapy and Other Innovative Options

Jessica Ailani, MD, FAHS, FAAN - From Migraine Recognition to Relief: Improving Outcomes With Patient-Centered CGRP Antagonist Strategies

Sarah Cuddy, MD / Ronald Witteles, MD - Expert Perspectives on Novel Approaches to Therapy for ATTR Cardiac Amyloidosis

Margaret H. Collins, MD, AGAF, Nirmala Gonsalves, MD, AGAF, FACG - Beyond the Eosinophil: Mastering the Complexities of EoE Diagnosis

Jared R. Brosch, MD - Leveraging Biomarkers to Optimize Treatment Outcomes With ATTs in Early Symptomatic Alzheimer’s Disease: New Data and Clinical Pearls From AAIC 2025

Naval Daver, MD, Ghayas Issa, MD - All Rise for Innovation in AML: Processing New Developments With Menin Inhibitors in Challenging AML Subtypes

Sami L. Khella, MD - Targeted Treatments for Transthyretin Amyloidosis: Essential Insights for Neurologists

Grzegorz (Greg) S. Nowakowski, MD, FASCO - Raising Frontline Expectations in DLBCL: Principles for Refining Upfront Treatment and Addressing Unmet Needs With Modern Antibody-Based Combinations

Donna D. Catamero, ANP-BC, OCN, CCRC / Joshua Richter, MD, FACP - At the Nexus of Sequential Care in Myeloma: Interprofessional and Patient Perspectives on GPRC5D-Directed Therapies

Ghassan Abou-Alfa, MD, JD, MBA, PhD (hc) - Immune to the Impossible in Hepatobiliary Malignancies: Expert Insights on Breakthrough Innovations for Immunotherapy Platforms in Advanced-Stage Disease

Professor Kausik Ray - Achieving Goals in Lipid Management: Then and Now

Yasmin Mohiuddin, DO / Greg Pontone, MD, MHS - The LEAD Initiative: Launchpad to Excellence in Alzheimer’s Disease: A Quality Improvement Project

Courtney Younglove, MD, FOMA, FACOG, DABOM - Collaborating With Peers to Optimize Obesity Management in Women: Clinical Considerations Before, During, and After Pregnancy

David Bernstein, MD, MACG, FAASLD, AGAF, FACP, Steven Flamm, MD, FAASLD, FACG - Transforming PBC Management: Targeted Relief and Improved Outcomes

Jacinda (JAM) Abdul-Mutakabbir, PharmD, MPH / Jewel Mullen, MD, MPH, MPA - Building Confidence in RSV Vaccination: Addressing Vaccine Hesitancy and Inequities in At-Risk Populations

Steven R. Feldman, MD, PhD - A New Era in GPP Treatment: Clinical Insights, Biomarkers, and Emerging Therapies

Jonathan L. Kaufman, MD - The Power Sequence in RRMM: Collaborative Approaches for Optimizing Sequential Treatment With Cellular and Off-the-Shelf Immunotherapy

Rafael J. Sepulveda, MD, D-ABOM - Beyond Snoring: Diving Into the Spectrum of OSA Screening Tools

Jaime Almandoz, MD, MBA, FTOS - Navigating Weight and Sleep: Best Practices for Nonjudgmental Weight Management in OSA Care

Sameh Gaballa, MD - Off-the-Shelf and on the Mark in NHL: Strategic Approaches With Bispecific Antibodies and ADCs

Hollis Day, MD, MS, MHPE - A Light on the Horizon: Improving Alzheimer's Screening and Diagnosis Through Quality Improvement

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO - Leading the Next Chapter of Myeloma Care: Oncology Nurse Stewardship in the Era of Innovative Antibodies and Cellular Therapies

Professor Jürgen Rockstroh / Dr. Laura Waters - Revisiting HIV Antiretroviral Drug Resistance in the Current Landscape: Expert Insights Into Cause, Consequence, and Clinical Approaches for Management

Erik Musiek, MD, PhD, Stephen Salloway, MD, MS - AD-SAFE: An Initiative to Build Understanding of ARIA and Skills Needed to Improve Detection and Optimize Response in Specialty Care

Caitlin Costello, MD - The BCMA Playbook in Multiple Myeloma: Mastering Sequential Strategies With Bispecific Antibodies and CAR-T Therapy

Lauren Edgar, DNP, MSN-Ed., RN, FNP - Nursing Strategies in Transthyretin Cardiac Amyloidosis: Targeted Therapies and the Patient Experience

Prof. Dr. med. Barbara Eichhorst - The Second Coming of Finite Therapy in CLL: Making Informed Treatment Decisions With Newer, Time-Limited BTKi Combinations

Joseph M. Coney, MD, FACS, FASRS - Eye on Equity: A Comprehensive Approach to DR/DME Care in Under-Represented Populations

Dr. Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD, Jennifer Woyach, MD - The Road Ahead for Enhanced Sequential Care in CLL—Updates With Targeted Therapy

Samuel Cytryn, MD, Yelena Y. Janjigian, MD* - Achieving Excellence in Gastric/GEJ Cancer Care: Multidisciplinary Guidance on Immunotherapy Platforms in Resectable Disease

Shervin Assassi, MD, MS - The Evolving Landscape of Fibrosing Interstitial Lung Diseases: Equipping Clinicians to Enhance Patient Care in the Era of Antifibrotic Therapy

Pier Luigi Zinzani, MD, PhD - Upfront Upgrades for Mantle Cell Lymphoma: Integrating the First-Line Use of BTKi Strategies Across Patient Populations

Sagar Lonial, MD, FACP - 4x4 in Multiple Myeloma: Maintaining Momentum for Delivering Innovative Care in Newly Diagnosed and Relapsed Disease

Simron Singh, MD, MPH - Treatment Planning Made CLEAR in Neuroendocrine Tumors and Pancreatic Cancer: Personalized Integration of Validated and Emerging Therapies

"Prof. Wojciech Jurczak, MD, PhD - Staying on Track Toward Better CLL Outcomes: Delivering Effective Sequential Care Guided by Real-World Experience"

Jacob Sands, MD - Tailwinds of Innovation in SCLC: Exploring the Therapeutic Potential of ADCs

Prof. Dr. Peter R. Galle - Purpose in Practice for HCC: Delivering Effective Care With Modern Systemic Platforms Across Disease Settings

Joshua Sabari, MD - Precision Matters in NSCLC: Everything You Need to Know About Biomarker Testing and Targeted Therapies

Andres Deik, MD, MSEd, FAAN / Ozlem Goker-Alpan, MD - Cracking the Code of GBA1-Associated Parkinson’s Disease and Lysosomal Storage Disorders: Transforming Diagnosis and Management

Heinz-Josef Lenz, MD, FACP - Catalysts for Redefined Care in Colorectal Cancer: Adapting Systemic Therapy Regimens Across Disease Settings

Elias Jabbour, MD / Ibrahim Aldoss, MD - ALL-in on Bispecific Innovation: Guidance on the Present and Future of Off-the-Shelf Immunotherapy in Acute Lymphoblastic Leukemia